Novo Nordisk relocates regional headquarters from Athens to Istanbul

Zaman - Danish drug maker Novo Nordisk has joined the string of multinational companies running their Middle Eastern and North African operations from Istanbul, Turkey. The company’s choosing of Istanbul as its regional headquarters is largely based on Turkey’s role model status for the region, according to company executive, Lars Rebien Sorensen. Novo Nordisk is a major supplier of diabetes medications.
turkey; istanbul; healthcare sector; pharmaceuticals; drug maker; novo nordisk; regional center; regional base; diabetes